Pre‐existing psoriasis and immune‐related adverse events following immunotherapy for lung cancer

Documenti analoghi

• Effect of GLP‐1RA on mortality and cardiovascular risk in adults with psoriasis and type 2 diabetes
  di: Claire Lin, et al.
  Pubblicazione: (2026)
• Risk of adverse events of psoriasis treatment with biologic agents and new small molecules—BIOBADADERM Registry
  di: María Olivares‐Guerrero, et al.
  Pubblicazione: (2025)
• Dermatologic immune‐related adverse events: It is time for a game change!
  di: Davide Fattore, et al.
  Pubblicazione: (2024)
• Prevention and management of cutaneous immune‐related adverse events: EADV Task Force statement
  di: Davide Fattore, et al.
  Pubblicazione: (2025)
• Severe adverse drug reactions induced by lamotrigine: Are prescription guidelines being followed?
  di: Alice Thorn, et al.
  Pubblicazione: (2025)